Prothrombotic role of antiphospholipid antibodies in a patient with sickle cell disease
-
Published:2022
Issue:3
Volume:9
Page:362-366
-
ISSN:2375-1576
-
Container-title:AIMS Medical Science
-
language:
-
Short-container-title:AIMSMEDS
Author:
Petrungaro Annamaria,Quartarone Eugenia,Rigoli Luciana,Sciarrone Paolo
Abstract
<abstract>
<p>Sickle cell disease (SCD) is a common inherited condition in African, Caribbean, and Mediterranean countries. SCD is a hematologic disorder caused by a well-characterized point mutation in the β-globin gene, which produces an abnormal hemoglobin S that results in the sickling of red blood cells in deoxygenated conditions. Patients with SCD display a “hypercoagulation state” leading to an increased risk of severe venous and arterial thrombotic vascular events. Herein we report a case of severe thrombotic complications in a patient with SCD who showed high antiphospholipid antibodies (APA) levels during vascular occlusions.</p>
</abstract>
Publisher
American Institute of Mathematical Sciences (AIMS)